###begin article-title 0
###xml 49 58 49 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
Two non-homologous brain diseases-related genes, SERPINI1 and PDCD10, are tightly linked by an asymmetric bidirectional promoter in an evolutionarily conserved manner
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 595 603 595 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1</italic>
###xml 661 667 661 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 971 980 971 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 984 990 984 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
Despite of the fact that mammalian genomes are far more spacious than prokaryotic genomes, recent nucleotide sequencing data have revealed that many mammalian genes are arranged in a head-to-head orientation and separated by a small intergenic sequence. Extensive studies on some of these neighboring genes, in particular homologous gene pairs, have shown that these genes are often co-expressed in a symmetric manner and regulated by a shared promoter region. Here we report the identification of two non-homologous brain disease-related genes, with one coding for a serine protease inhibitor (SERPINI1) and the other for a programmed cell death-related gene (PDCD10), being tightly linked together by an asymmetric bidirectional promoter in an evolutionarily conserved fashion. This asymmetric bidirectional promoter, in cooperation with some cis-acting elements, is responsible for the co-regulation of the gene expression pattern as well as the tissue specificity of SERPINI1 and PDCD10.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 6 15 6 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 94 101 94 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 458 465 458 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 698 707 698 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 727 733 727 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
While SERPINI1 is predominantly expressed in normal brain and down-regulated in brain tumors, PDCD10 is ubiquitously expressed in all normal tissues but its gene transcription becomes aberrant in different types of cancers. By measuring the luciferase activity in various cell lysates, their 851-bp intergenic sequence was shown to be capable of driving the reporter gene expression in either direction. A 175-bp fragment from nt 1 to 175 in the vicinity of PDCD10 was further determined to function as a minimal bidirectional promoter. A critical regulatory fragment, from nt 176-473 outside the minimal promoter in the intergenic region, was identified to contain a strong repressive element for SERPINI1 and an enhancer for PDCD10. These cis-acting elements may exist to help coordinate the expression and regulation of the two flanking genes.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 145 151 145 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 152 161 152 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
For all non-homologous genes that have been described to be closely adjacent in the mammalian genomes, the intergenic region of the head-to-head PDCD10-SERPINI1 gene pair provides an interesting and informative example of a complex regulatory system that governs the expression of both genes not only through an asymmetric bidirectional promoter, but also through fine-tuned regulations with some cis-acting elements.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 7 12 <span type="species:ncbi:9606">human</span>
###xml 263 268 <span type="species:ncbi:9606">human</span>
In the human genome, there are over 550 genes coding for proteases with another 150 being protease inhibitors [1]. While the majority of protease genes belong to three different classes including serine, metallo- and cysteine proteases, a large portion (~25%) of human protease inhibitor genes belong solely to just one family: the serpin family.
###end p 9
###begin p 10
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 367 374 367 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINA</italic>
###xml 376 383 376 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINB</italic>
###xml 385 393 385 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINC </italic>
###xml 408 416 408 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI </italic>
###xml 427 428 427 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 429 430 429 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 577 585 577 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINA </italic>
###xml 652 660 652 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINB </italic>
###xml 734 735 734 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 736 737 736 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 758 766 758 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI </italic>
###xml 871 880 871 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 881 883 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 940 949 940 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI2 </italic>
###xml 950 952 950 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1070 1072 1070 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 267 273 <span type="species:ncbi:9606">humans</span>
The serpin family comprises hundreds of structurally homologous proteins that are present in both eukaryotic and prokaryotic organisms [2-4]. Its members include inhibitors of serine proteases as well as non-inhibitory members with other biological functions [5]. In humans, a total of 35 serpin-coding genes were identified and grouped into 9 subfamilies designated SERPINA, SERPINB, SERPINC and so on till SERPINI subfamily [2,3]. Each subfamily has its own specific chromosomal localization and well-conserved exon-intron arrangement. For example, nearly all members of the SERPINA subfamily are located at chromosome 14q32 and genes coding for the SERPINB subfamily are clustered at two distinct chromosomal loci: 6p25 and 18q21 [6-9]. Even for the last SERPINI subfamily, although consists of only two genes with one coding for a brain-associated protease inhibitor SERPINI1 [10] and another for a pancreas-specific protease inhibitor SERPINI2 [11], its two members are closely adjacent at chromosome 3q26 and share a perfectly conserved gene organization pattern [12].
###end p 10
###begin p 11
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1</italic>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 388 397 388 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 656 657 656 657 <underline xmlns:xlink="http://www.w3.org/1999/xlink">f</underline>
###xml 665 666 665 666 <underline xmlns:xlink="http://www.w3.org/1999/xlink">e</underline>
###xml 685 686 685 686 <underline xmlns:xlink="http://www.w3.org/1999/xlink">n</underline>
###xml 697 698 697 698 <underline xmlns:xlink="http://www.w3.org/1999/xlink">i</underline>
###xml 707 708 707 708 <underline xmlns:xlink="http://www.w3.org/1999/xlink">b</underline>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 794 803 794 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 939 948 939 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI2 </italic>
###xml 982 984 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1036 1045 1036 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 1202 1209 1202 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 1257 1266 1257 1266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 1118 1123 <span type="species:ncbi:9606">human</span>
SERPINI1, also known as neuroserpin or protease inhibitor 12, is an axonally secreted serine protease inhibitor found in the nervous systems [10]. It functions as a selective inhibitor of tissue-type plasminogen activator and is involved in a wide range of neuronal processes including synaptic plasticity [10,13], neuronal migration [14,15] and axogenesis [15,16]. Genetic variations of SERPINI1 have been reported to render the enzyme conformation locked as an inactive folding intermediate [17-20]. These mutant proteins then undergo spontaneous polymerization within neurons and cause a severe progressive neurodegenerative encephalopathy named FENIB (familial encephalopathy with neuroserpin inclusion bodies) [21,22]. In addition to the mutations at the DNA level, the mRNA expression of SERPINI1 was found to be down-regulated or lost in brain tumors [12]. These abnormalities, along with our latest findings that its adjacent gene SERPINI2 is also down-regulated in cancer [12], prompted us to study the regulatory mechanism of SERPINI1 gene in both normal and cancerous brain tissues. Interestingly, when the human genome sequence became available, it came to our attention that a gene termed PDCD10 was mapped to lie at less than 1 kb upstream of SERPINI1 in a divergent, head-to-head orientation.
###end p 11
###begin p 12
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFAR15 </italic>
###xml 44 46 44 46 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TF</underline>
###xml 54 55 54 55 <underline xmlns:xlink="http://www.w3.org/1999/xlink">a</underline>
###xml 64 65 64 65 <underline xmlns:xlink="http://www.w3.org/1999/xlink">r</underline>
###xml 77 79 77 79 <underline xmlns:xlink="http://www.w3.org/1999/xlink">15</underline>
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 313 320 313 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 321 322 321 322 <underline xmlns:xlink="http://www.w3.org/1999/xlink">p</underline>
###xml 330 331 330 331 <underline xmlns:xlink="http://www.w3.org/1999/xlink">d</underline>
###xml 332 333 332 333 <underline xmlns:xlink="http://www.w3.org/1999/xlink">c</underline>
###xml 337 338 337 338 <underline xmlns:xlink="http://www.w3.org/1999/xlink">d</underline>
###xml 343 345 343 345 <underline xmlns:xlink="http://www.w3.org/1999/xlink">10</underline>
###xml 353 360 353 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 579 586 579 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 717 724 717 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 897 899 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 165 170 <span type="species:ncbi:9606">human</span>
###xml 445 450 <span type="species:ncbi:9606">human</span>
###xml 452 455 <span type="species:ncbi:9615">dog</span>
###xml 457 462 <span type="species:ncbi:10090">mouse</span>
###xml 467 474 <span type="species:ncbi:9031">chicken</span>
PDCD10 was originally identified as TFAR15 (TF-1 cell apoptosis related gene-15) for being up-regulated after the induction of apoptosis by serum withdrawal in TF-1 human premyeloid cells [23]. It was later grouped into a collection of genes thought to be involved in many apoptotic responses and thus renamed as PDCD10 (programmed cell death 10 gene). PDCD10 is highly conserved among different species, with over 99% amino-acid identity among human, dog, mouse and chicken. Although its physiological role remains unclear, a recent study showed that inhibition of the nematode PDCD10 ortholog led to embryonic lethality in 40% of the embryos and a dumpy phenotype in postembryonic viable embryos [24]. Furthermore, PDCD10 mutations were identified in families with cerebral cavernous malformation, indicating that this gene may play a role in the development of cerebral vascular morphogenesis [25].
###end p 12
###begin p 13
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 981 983 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1031 1037 1023 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCG5 </italic>
###xml 1041 1047 1033 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCG8 </italic>
###xml 1054 1056 1046 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1057 1059 1049 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1218 1227 1210 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 1231 1237 1223 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 1383 1390 1375 1382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPIN </italic>
###xml 1393 1398 1385 1390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD </italic>
###xml 1422 1431 1414 1423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 1435 1442 1427 1434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 1587 1596 1579 1588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 1600 1607 1592 1599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 1748 1757 1740 1749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 1761 1768 1753 1760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 332 337 <span type="species:ncbi:9606">human</span>
It is known that in prokaryotic and lower eukaryotic genomes, genes are often organized in a proximal pattern to facilitate gene co-expression and functional coupling. Increasing evidence suggests that many genes in mammalian genomes also tend to be in close physical vicinity. Recently, by conducting a genome-wide analysis of the human genome, Trinklein and his colleagues identified a class of head-to-head gene pairs whose transcriptional start sites are separated by less than 1 kb [26]. Since mammalian genomes are far more spacious than prokaryotic genomes, it seems unnecessary for two neighboring genes to be arranged in an adjacent head-to-head pattern unless they share a common regulatory system such as an intergenic bidirectional promoter. It is conceivable that bidirectional promoters of gene pairs may be able to co-regulate the genes in a more efficient manner. For example, for homologous gene pairs such as the pair of collagen type IV alpha1 and alpha2 genes [27] and the pair of ATP-binding cassette molecule ABCG5 and ABCG8 genes [28,29], their bidirectional promoters were shown to co-regulate the two genes thus ensuring the co-expressivity of the gene products. For non-homologous genes like SERPINI1 and PDCD10, however, the need for co-regulation is not as obvious. In addition, compared to all the other genes that are adjacently located to any of known SERPIN or PDCD genes, only the pair of SERPINI1 and PDCD10 genes were arranged in a head-to-head orientation and separated by an exceptionally short intergenic region. This close chromosomal proximity of SERPINI1 and PDCD10 and their divergent configuration are widely preserved in many species, implying that through the evolution there appears to have a need for SERPINI1 and PDCD10 to be tightly linked together to maintain gene co-regulation or functional association.
###end p 13
###begin p 14
###xml 54 63 54 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 135 142 135 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 350 359 350 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 363 370 363 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 571 580 571 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 607 613 607 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 890 896 890 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 897 906 897 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 834 839 <span type="species:ncbi:9606">human</span>
In this study, we present evidence showing that while SERPINI1 is predominantly expressed in brain and down-regulated in brain tumors, PDCD10 is ubiquitously expressed in all normal tissues but its gene transcription becomes aberrant in different types of cancers. We have also identified a 175-bp regulatory fragment within the intergenic region of SERPINI1 and PDCD10 that functions as a bidirectional promoter. Moreover, a critical fragment, from nt 176-473 outside the minimal promoter in this intergenic region, was found to possess a strong repressive activity for SERPINI1 and enhancing activity for PDCD10. These cis-acting elements may exist to coordinate the expression and regulation of the two flanking genes. To the best of our knowledge, of all non-homologous genes that have been reported to be closely adjacent in the human genome, the intergenic region of the head-to-head PDCD10-SERPINI1 pair at 3q26 exhibits by far the most complex regulatory function that governs the expression of both genes not only through an asymmetric bidirectional promoter, but also through regulations with some other cis-acting elements.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
###xml 23 32 23 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
Expression patterns of SERPINI1 and PDCD10 in normal and cancerous tissues
###end title 16
###begin p 17
###xml 49 58 49 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 199 208 199 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 309 316 309 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 427 436 427 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 440 449 440 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI2 </italic>
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 567 573 567 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 611 619 611 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI </italic>
###xml 743 752 743 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 831 838 831 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 887 888 887 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 952 959 952 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 1012 1019 1012 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 1130 1131 1130 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 111 116 <span type="species:ncbi:9606">human</span>
In order to explore the distribution patterns of SERPINI1 and PDCD10, we performed Northern blot analysis on a human multiple tissue expression array of poly A+ RNAs. As illustrated in Fig. 1, while SERPINI1 expression was observed mainly in different parts of brain, hybridization of the same array with the PDCD10 probe revealed that it was ubiquitously expressed as a housekeeping gene in all tissues analyzed. Moreover, as SERPINI1 and SERPINI2 were both reported to be down-regulated during tumor development [12], it is rational to doubt that the expression of PDCD10, which is located in between the two SERPINI genes at chromosome 3q26, may also be altered in some tumors. Results from the semi-quantitative RT-PCR indicate that while SERPINI1 expression was negatively correlated with tumor progression, the mRNA level of PDCD10 was not much affected in brain tumor cells (Fig. 2). Furthermore, when we investigated the expression patterns of PDCD10 in other normal and cancerous tissues, we found that PDCD10 was up-regulated in various cancers including ovarian, stomach, lung, uterus and small intestine cancers (Fig. 2).
###end p 17
###begin title 18
###xml 69 78 69 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 82 89 82 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 63 68 <span type="species:ncbi:9606">human</span>
Determination of the distance of the intergenic region between human SERPINI1 and PDCD10 genes
###end title 18
###begin p 19
###xml 62 71 62 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 75 82 75 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 274 283 274 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 320 327 320 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 525 532 525 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 576 585 576 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 664 671 664 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 675 684 675 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 841 842 841 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 845 846 845 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 241 246 <span type="species:ncbi:9606">human</span>
###xml 470 475 <span type="species:ncbi:9606">human</span>
After analyzing the distribution of mRNA transcripts for both SERPINI1 and PDCD10 genes, we then attempted to pinpoint their precise transcriptional start sites in order to determine the length of their intergenic spacer. As revealed by the human genome reference sequence, SERPINI1 [accession number EMBL:BC018043] and PDCD10 [accession number EMBL:AF022385] were mapped in a head-to-head configuration at 3q26 and separated by less than 1 kb. By performing 5'-RACE on human brain RNA, three transcriptional start sites for PDCD10 but only one transcriptional start site for SERPINI1 were identified. The closest transcriptional start site that we identified for PDCD10 and SERPINI1 were at 5 and 15 bp respectively upstream of the sites predicted by NCBI database, thus the shortest intergenic distance was recalculated to be 851 bp (Fig. 3 & 4).
###end p 19
###begin title 20
Characterization of the asymmetric bidirectional promoter activity of the intergenic region
###end title 20
###begin p 21
###xml 142 151 142 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 155 162 155 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 637 646 637 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Serpini1 </italic>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 721 730 721 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 733 740 733 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 1003 1004 1003 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1051 1058 1051 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 1131 1139 1131 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1</italic>
###xml 1186 1195 1186 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 1385 1386 1385 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1505 1514 1505 1514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 1518 1525 1518 1525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 269 274 <span type="species:ncbi:9606">human</span>
###xml 501 504 <span type="species:ncbi:10116">rat</span>
###xml 631 636 <span type="species:ncbi:10090">mouse</span>
###xml 1357 1361 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Following the mapping of the transcriptional start sites, the 851-bp intergenic fragment constituting the putative regulatory region for both SERPINI1 and PDCD10 genes was analyzed for its transcriptional activities by driving the firefly luciferase reporter gene. The human cell lines utilized for luciferase reporter assays include brain neuroglioma H4, brain glioblastoma U-87 MG, ovarian adenocarcinoma OVTW-59-4, lung adenocarcinoma CL1-5, and cervical adenocarcinoma HeLa cancer cell lines. The rat adrenal gland pheochromocytoma PC-12 cell line was also used for comparison as it had previously been chosen for the study of mouse Serpini1 promoter [30]. The full-length 851-bp fragments in either direction toward SERPINI1 or PDCD10 were cloned into the reporter vector (pGL3-Basic). By measuring the luciferase activity in various cell lysates after transient transfection, the 851-bp intergenic sequence was shown to be capable of driving the reporter gene expression in either direction (Fig. 3). The promoter activities in the direction of PDCD10 in all cells tested were approximately 4 to 10-fold higher than those of SERPINI1. Moreover, the promoter activities toward the SERPINI1 direction were higher in brain tumor H4 and U-87 MG cells than those in other test cells, and they were nearly 3-fold higher than the positive control, the viral SV40 minimal promoter (Fig. 3). These results indicate that the 851-bp intergenic region is able to function as a bidirectional promoter to control SERPINI1 and PDCD10 expressions, and some regulatory elements within this region may asymmetrically regulate the transcription of both genes.
###end p 21
###begin title 22
Interspecies comparison of the 851-bp intergenic region and analysis of the putative cis-regulatory elements within this region
###end title 22
###begin p 23
###xml 56 65 56 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 69 76 69 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 546 553 546 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 849 850 849 850 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 851 852 851 852 <sub xmlns:xlink="http://www.w3.org/1999/xlink">C</sub>
###xml 104 109 <span type="species:ncbi:9606">human</span>
###xml 227 232 <span type="species:ncbi:9606">human</span>
###xml 234 239 <span type="species:ncbi:10090">mouse</span>
###xml 244 247 <span type="species:ncbi:10116">rat</span>
###xml 755 760 <span type="species:ncbi:9606">human</span>
To understand whether the head-to-head configuration of SERPINI1 and PDCD10 is a unique feature only in human or if it is evolutionary conserved in other mammals, we aligned the homologous regions between these two genes among human, mouse and rat by the Vector NTI program (InforMax, Bethesda, MD, USA). The results revealed that both the gene order and the compact head-to-head arrangement are conserved in different species (data not shown), and that within the intergenic region there is an approximately 400-bp fragment near the vicinity of PDCD10 with the highest percent identity (Fig. 4A). Based on the nucleotide sequence shown in Fig. 4B, the 851-bp intergenic region has a GC content of 65%, which is much higher than the average of the entire human genome (41%). While no TATA-box is observed in this region, two CAAT boxes (consensus GGT/CCAATCT) are noted in the most conserved 400-bp fragment with a 100-bp distance from each other. In addition, within this highly conserved fragment, there are one neuron-specific AP-2, one c-Myc and one NFkappaB binding motives as well as several binding sites for the general transcription factor Sp1 as predicted by MatInspector (Genomatix; ) and TFSEARCH programs (Computational Biology Research Center; ). The presence and conservation of these putative binding motives suggest that some of these transcription factors must possess an important evolutionary significance and some yet-unknown regulatory demands.
###end p 23
###begin title 24
Identification of the key regulatory region of the bidirectional promoter by deletion analysis
###end title 24
###begin p 25
###xml 61 70 61 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 74 81 74 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 417 426 417 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 457 466 457 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 611 620 611 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 647 648 647 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 783 792 783 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 872 881 872 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 982 989 982 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 1339 1348 1339 1348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 1423 1430 1423 1430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 1446 1447 1446 1447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1579 1588 1579 1588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 1633 1640 1633 1640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 1765 1772 1765 1772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 1896 1905 1896 1905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 1909 1915 1909 1915 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
To identify the key regulatory DNA sequences responsible for SERPINI1 and PDCD10 gene expressions, we constructed a series of plasmids containing various intergenic promoter regions derived from the 851-bp sequence. By using the same reporter system addressed in Fig. 3, the luciferase activities of these constructs were assessed by transient transfection into H4 cells. Due to the neuron-specific expression of the SERPINI1 gene, the promoter activity of SERPINI1 in neuron cells is higher than those in cells from other tissues. Thus, H4 cells were used as a vehicle for studying the regulatory mechanism of SERPINI1 promoter. As shown in Fig. 5, removal of the sequence from nt 1 to 175 completely abolished luciferase activity compared to the full-length 851-bp fragment in the SERPINI1 direction, suggesting that this 175-bp fragment is important for the control of SERPINI1 gene expression. This fragment alone was also capable of driving the reporter gene expression in the PDCD10 direction. Further splitting of this bidirectional promoter region into two parts, i.e. the sequence from nt 1 to 107 or from nt 108 to 175, resulted in a dramatic loss of luciferase activity. Surprisingly, deletion of the fragment of nt 176 to 851 increased more than 3-fold of the luciferase activity relative to that of the 851-bp fragment in the SERPINI1 direction but only kept a ~40% remaining of the luciferase activity in the PDCD10 direction (Fig. 5). These results strongly indicate that within the fragment of nt 176-851 there likely exist a repressive element that can regulate SERPINI1 expression and an enhancer that can modulate PDCD10 expression. Based on these findings, we conclude that a 175-bp minimal promoter region from nt 1 to 175 near the vicinity of PDCD10 and a regulatory region outside the 175-bp fragment from nt 176 to 851 may coordinately regulate the gene transcriptions of SERPINI1 and PDCD10.
###end p 25
###begin title 26
###xml 49 58 49 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 79 85 79 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
Possible locations of the repressive element for SERPINI1 and the enhancer for PDCD10
###end title 26
###begin p 27
###xml 38 39 38 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 188 197 188 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 217 223 217 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 444 451 444 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 607 614 607 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 630 631 630 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 714 722 714 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1</italic>
###xml 307 311 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 382 386 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 486 490 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 671 675 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
From the experiment described in Fig. 5, there seems to exist a regulatory fragment from nt 176 to 851 which possesses no promoter activity but appears to contain a repressive element for SERPINI1 and an enhancer for PDCD10. Thus, we cloned this fragment in two opposite directions into the upstream of the SV40 promoter in a pGL3-Promoter vector, and examined their effects on the SV40 promoter. As expected, the fragment of nt 176-851 in the PDCD10 direction was able to increase the SV40 promoter activity for approximately 2.2-fold (Fig. 6A). This observation confirmed the existence of an enhancer for PDCD10 as seen in Fig. 5. However, there was no increase of the SV40 promoter activity in the direction of SERPINI1. This phenomenon was possibly a compromising effect resulted from the coordination between the enhancer and the repressive element within the regulatory region; the extent of such effect may also vary for using different heterologous promoters.
###end p 27
###begin p 28
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 192 199 192 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 483 492 483 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 692 698 692 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 748 756 748 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1</italic>
###xml 1051 1060 1051 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 1157 1159 1157 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 1237 1244 1237 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 1479 1488 1479 1488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 1515 1521 1515 1521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 259 263 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 404 408 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 528 532 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 878 881 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 921 925 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1129 1132 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1278 1281 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
To further identify the enhancer responsible for PDCD10, three intergenic fragments including 1) the nt 176-473 fragment, 2) the nt 474-710 fragment, and 3) the nt 711-851 fragment toward the PDCD10 direction were individually cloned into the upstream of the SV40 promoter and assayed for their promoter activity in H4 cells. The results showed that only the nt 473-176 fragment was able to increase the SV40 promoter activity by 6 to 10-fold (Fig. 6B). The same fragment toward the SERPINI1 direction had no such effect on the SV40 promoter activity (data not shown). Hence, there is an orientation-dependent enhancer located in the fragment of nt 176-473 and acting on the transcription of PDCD10. As for the search of the repressive element for SERPINI1, the same fragments but in opposite direction were individually cloned into a modified pGL3-Promoter vector containing a CMV promoter, a stronger promoter than the SV40 and better for repressive activity studies. The assay results demonstrated that only the fragment from nt 176-473 toward the SERPINI1 direction possessed a repressive ability which inhibited ~70% of the CMV promoter activity (Fig. 6C). Nonetheless, the same fragment but in the opposite orientation (toward the PDCD10 direction) could only enhance the CMV promoter activity for approximately 2-fold (data not shown). These findings signify that a critical fragment from nt 176-473 outside the minimal promoter possesses a strong repressive activity for SERPINI1 and enhancing activity for PDCD10.
###end p 28
###begin title 29
Discussion
###end title 29
###begin p 30
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 363 369 363 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 419 428 419 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 609 616 609 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 620 629 620 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 824 831 824 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 1131 1138 1131 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 1207 1208 1207 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1392 1394 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1510 1517 1510 1517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 1558 1567 1558 1567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 1573 1574 1573 1574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 1637 1646 1637 1646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Serpini1 </italic>
###xml 1647 1649 1647 1649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1724 1733 1724 1733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Serpini1 </italic>
###xml 1860 1869 1860 1869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 1937 1946 1937 1946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Serpini1 </italic>
###xml 2360 2368 2360 2368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Serpini1</italic>
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 207 212 <span type="species:ncbi:9606">human</span>
###xml 855 860 <span type="species:ncbi:9606">human</span>
###xml 862 867 <span type="species:ncbi:10090">mouse</span>
###xml 872 875 <span type="species:ncbi:10116">rat</span>
###xml 1300 1305 <span type="species:ncbi:9606">human</span>
###xml 1362 1365 <span type="species:ncbi:10116">rat</span>
###xml 1631 1636 <span type="species:ncbi:10090">mouse</span>
###xml 1844 1849 <span type="species:ncbi:9606">human</span>
###xml 1854 1859 <span type="species:ncbi:10090">mouse</span>
###xml 1931 1936 <span type="species:ncbi:10090">mouse</span>
###xml 2300 2303 <span type="species:ncbi:10116">rat</span>
It has long been suggested that the human serpin genes are evolved from the same ancestor through intra- and interchromosomal duplications to develop into different clusters [31-33]. Interestingly, when the human genome sequence was unveiled a few years ago, several non-homologous genes were found to be mapped into the serpin gene clusters. One of these genes, PDCD10, not only forms a head-to-head organization with SERPINI1 at chromosome 3q26 but also shares a tiny promoter with it. The organization of this divergent gene pair is well preserved in many species throughout the evolution, indicating that PDCD10 and SERPINI1 need to be tightly together to maintain the gene co-regulation or their functional association. Further sequence analysis on the intergenic region revealed a 400-bp fragment near the vicinity of PDCD10 is highly similar among human, mouse and rat, a result strongly indicating that the transcriptional regulation mechanisms of these two genes are evolutionary conserved among different species. Indeed, by performing a series of luciferase assays, a 175-bp fragment from nt 1 to 175 in the vicinity of PDCD10 was determined to function as a minimal promoter of both genes (Fig. 5). The same 175-bp minimal promoter was also observed (data not shown) when we utilized the human intergenic fragment to perform the promoter analysis in rat adrenal gland PC12 cells [30]. In addition, we detected the existence of an important regulatory fragment from nt 176 to 473 in the vicinity of PDCD10 that possesses a repressive activity for SERPINI1 (Fig. 6). These findings are different from a previous study on mouse Serpini1 [30] claiming that a 200-bp segment near the transcription initiation site of Serpini1 was responsible for promoter activity. There are at least two possible reasons for the discrepancy observed in human and mouse SERPINI1 promoter. First, the constructs used for promoter analysis of mouse Serpini1 were all derived from 5' deletions of the full-length promoter region. These constructs might have contained the repressive element and/or lost the minimal promoter, and thus have very low promoter activities which could not be differentiated from each other. Secondly, different cell lines chosen might result in different conclusions; particularly the rat adrenal gland cell line PC12 has very low expression of Serpini1.
###end p 30
###begin p 31
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 619 626 619 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 630 638 630 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1</italic>
###xml 1041 1048 1041 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 1052 1061 1052 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 1161 1168 1161 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 1172 1181 1172 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 194 199 <span type="species:ncbi:9606">human</span>
Trinklein and colleagues have pointed out that divergently transcribed gene pairs whose transcriptional start sites are separated by less than 1 kb represent more than 10% of genes in the whole human genome [26]. Such a high proportion indicates that there is a biological importance for those adjacent gene pairs even through a long evolution. Two feasible explanations for the existence of bidirectional promoters in the mammalian genome were recently given by Zhang and colleagues [34]. The first explanation is that they are the ancestral sequences survived in evolution. A bidirectional promoter, like the one for PDCD10 and SERPINI1, with the characteristics of TATA-less, GC-rich and multiple Sp1 sites was thought to be the preserved ancestral sequences. The second explanation is that the genes sharing the bidirectional promoter are functionally related. From the sequence alignment data, we observed that this highly conserved promoter sequence is maintained throughout the evolution. Besides, there are evidences indicating that PDCD10 and SERPINI1 are both related to brain diseases. Therefore, we suggest that the compact adjacent arrangement for PDCD10 and SERPINI1 might be due to the possibility that they are involved in the same biological pathway.
###end p 31
###begin p 32
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 22 31 22 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 225 230 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PARK2</italic>
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PACRG</italic>
###xml 331 337 331 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 338 347 338 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 358 367 358 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 371 377 371 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 379 385 379 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PARK2 </italic>
###xml 389 395 389 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PACRG </italic>
###xml 420 425 420 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PARK2</italic>
###xml 432 440 432 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1</italic>
###xml 538 544 538 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PACRG </italic>
###xml 577 583 577 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 615 620 615 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PACRG</italic>
###xml 621 627 621 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PARK2 </italic>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 695 697 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 738 747 738 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 751 757 751 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PARK2 </italic>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 861 863 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 79 84 <span type="species:ncbi:9606">human</span>
Apart from the PDCD10-SERPINI1 gene pair at chromosome 3q26, there was another human head-to-head gene pair found to be associated with brain diseases [35]. This gene pair, consisting of the parkinsonism-related parkin gene (PARK2) and parkin co-regulated gene (PACRG) at chromosome 6q25.2-27, has many features in common with the PDCD10-SERPINI1 pair. Like SERPINI1 and PDCD10, PARK2 and PACRG are also non-homologous. PARK2, like SERPINI1, has its tissue specificity and is mainly expressed in brain, heart, skeletal muscle and kidney. PACRG is expressed in all tissues like PDCD10. The bidirectional promoter of PACRG-PARK2 is also TATA-less, GC-rich, and with multiple Sp1 binding sites [35,36]. Furthermore, the genetic mutations of SERPINI1 and PARK2 are able to accelerate the formation of cellular inclusion bodies and to cause the dementia symptom [18,21,37]. Therefore, we suggest that brain, being the most sophisticated organ which controls almost all responses of the whole body, may use bidirectional promoters to achieve gene expressions more efficiently, especially in the pathogenesis of its diseases.
###end p 32
###begin p 33
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 131 137 131 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 138 147 138 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 227 228 227 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 477 478 477 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 569 576 569 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 604 605 604 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 691 693 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 696 698 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 819 825 819 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryab </italic>
###xml 849 855 845 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hspb2 </italic>
###xml 891 893 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1021 1030 1017 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 1177 1178 1173 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1181 1182 1177 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 1360 1367 1356 1363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 1371 1380 1367 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 788 793 <span type="species:ncbi:10090">mouse</span>
###xml 971 976 <span type="species:ncbi:9606">human</span>
Gene expression and tissue specificity are often regulated by transcriptional activators or repressors [38-40]. In the case of the PDCD10-SERPINI1 gene pair, it is apparent that these two genes are not co-expressed genes (Fig. 1). This phenomenon can be best explained by the existence of a critical fragment, from nt 176 to 473 of the intergenic sequence, which contains an enhancer and a repressive element to coordinately regulate the transcriptions of both genes (Fig. 5 & 6). The intergenic enhancer is orientation-dependent exerting its effect on the promoter of PDCD10 in the native context (Fig. 5). It also works in an orientation-dependent manner with heterologous promoters (Fig. 6A & 6B). Previously, a similar orientation-dependent intergenic enhancer had been reported in a mouse gene pair: the divergent Cryab (alphaB-crystallin) and Hspb2 (heat shock 27 kDa protein 2) pair [41]. However, this is the first time that such an enhancer is identified in the human genome. Moreover, the neuron-specificity of SERPINI1 and its down-regulation in brain tumorigenesis may be accounted for by a repressive element located in the same critical regulatory fragment (Fig. 5 & 6). Together these results suggest that the fine coordination between the orientation-dependent cis-control elements may play an important role in the asymmetrical expressions of PDCD10 and SERPINI1 in different tissues. In addition to the cis-control elements, the possible involvement of certain trans-acting factors in this bidirectional promoter region need to be further elucidated.
###end p 33
###begin title 34
Conclusion
###end title 34
###begin p 35
###xml 79 88 79 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 92 98 92 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 301 308 301 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 530 539 530 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 559 566 559 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 771 777 771 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 778 787 778 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 715 720 <span type="species:ncbi:9606">human</span>
Here we present evidence that two non-homologous brain diseases-related genes, SERPINI1 and PDCD10, are tightly linked in a divergent configuration by a bidirectional promoter in an evolutionarily conserved fashion. Within their tiny intergenic region, a segment from nt 1 to 175 near the vicinity of PDCD10 was identified to function as a minimal promoter to efficiently drive the expressions of the two flanking genes. A critical regulatory fragment from nt 176 to 473 was further determined to contain a repressive element for SERPINI1 and an enhancer for PDCD10 that coordinately regulate the transcriptions of both genes. For all the non-homologous genes that have been described to be closely adjacent in the human genome, the intergenic region of the head-to-head PDCD10-SERPINI1 gene pair at 3q26 exhibits an interesting and informative example of a complex regulatory system that governs the expression of both genes not only through an asymmetric bidirectional promoter, but also through fine-tuned regulations with some cis-acting elements.
###end p 35
###begin title 36
Methods
###end title 36
###begin title 37
Cell culture
###end title 37
###begin p 38
###xml 812 814 806 808 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 133 139 <span type="species:ncbi:9913">bovine</span>
###xml 183 188 <span type="species:ncbi:9606">human</span>
###xml 217 222 <span type="species:ncbi:9606">human</span>
###xml 337 342 <span type="species:ncbi:9606">human</span>
###xml 373 378 <span type="species:ncbi:9606">human</span>
###xml 479 484 <span type="species:ncbi:9606">human</span>
###xml 613 616 <span type="species:ncbi:10116">rat</span>
###xml 719 724 <span type="species:ncbi:9796">horse</span>
All culture media, except RPMI 1640 medium, were purchased from Gibco Invitrogen (Carlsbad, CA, USA) and supplemented with 10% fetal bovine serum (FBS) (HyClone, Logan, UT, USA). H4 (human neuroglioma) and OVTW-59-4 (human ovarian adenocarcinoma) cells were cultured in DMEM (Dulbecco's modified Eagle's medium) medium, whereas U-87 MG (human brain glioblastoma) and HeLa (human cervical adenocarcinoma) cells were grown in minimum essential medium (MEM). CL1-5 (high-metastatic human lung adenocarcinoma) cells were cultured in RPMI-1640 medium (Hyclone) supplemented with 0.5 mM L-glutamine and 10% FBS. PC-12 (rat adrenal gland pheochromocytoma) cells were cultured in 85% RPMI-1640 supplemented with 5% FBS and 10% horse serum. All cell lines were maintained at 37degreesC in a humidified atmosphere of 5% CO2 in air.
###end p 38
###begin title 39
Northern blotting
###end title 39
###begin p 40
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 102 111 102 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 542 549 512 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 1378 1380 1314 1316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 156 161 <span type="species:ncbi:9606">human</span>
###xml 1521 1526 <span type="species:ncbi:9606">human</span>
Northern hybridizations were carried out mainly as described previously [12]. In brief, the probe for SERPINI1 was amplified from the FirstChoice PCR-Ready human brain cDNA (Ambion, Austin, TX, USA) using the forward primer 5'-CTGGAAGTCGCAGTTTAGGCCTGAA-3' and the reverse primer 5'-TGGATGGTCGACAATAACTTGAGGA-3' to produce a 559-bp fragment under the following conditions: 1 cycle of 94degreesC for 5 min; 32 cycles of 94degreesC for 20 sec, 55degreesC for 20 sec, and 72degreesC for 1 min; and 1 cycle of 72degreesC for 10 min. The probe for PDCD10 was amplified from the same cDNA using the forward primer 5'-TCCATGGTTTCTATGCCCCT-3' and the reverse primer 5'-TTTGGTGTTCAAGTGCCCTG-3' to produce a 445-bp fragment under the following conditions: 1 cycle of 94degreesC for 5 min; 35 cycles of 94degreesC for 30 sec, 55degreesC for 30 sec, and 72degreesC for 30 sec; and 1 cycle of 72degreesC for 10 min. All PCRs were performed on a T3 thermocycler (Whatman Biometra, Goettingen, Germany) using Ex Taq polymerase (Takara, Otsu, Singa, Japan) and subjected to sequencing on an ABI PRISM 3700 automated sequencer (Applied Biosystems, Foster City, CA, USA) by the core facility of the National Health Research Institutes (Zhunan, Taiwan). The sequence-verified probes, including a cDNA probe for ubiquitin supplied by the manufacturer and used as a control, were labeled with [alpha-32P]dCTP using the Rediprime II DNA labeling system (Amersham/GE Healthcare, Piscataway, NJ, USA) followed by hybridization against either the human MTE multiple tissue expression array or cancer profiling array (BD Bioscience Clontech, Palo Alto, CA, USA) in an ExpressHyb hybridization solution (BD Bioscience Clontech) for 4 h at 65degreesC. The arrays were then washed and exposed to X-ray film for detection. Each Northern blot analysis was repeated at least three times to confirm reproducibility of the results.
###end p 40
###begin title 41
Semi-quantitative reverse transcription polymerase chain reaction (RT-PCR)
###end title 41
###begin p 42
###xml 667 676 654 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 966 973 923 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 1246 1252 1173 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
###xml 1455 1461 1382 1388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
###xml 1488 1494 1415 1421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 35 40 <span type="species:ncbi:9606">human</span>
Total RNAs were extracted from two human brain tumor cell lines, H4 and U-87 MG, using TRIZOL reagent (Gibco Invitrogen) followed by DNase (Ambion) treatment to eliminate potential genomic DNA contamination. For control, total RNA of normal brain tissue was obtained from Clontech. Complementary DNA (cDNA) was synthesized from 5 mug of total RNA using oligo(dT) priming (Roche Molecular Biochemicals, Indianapolis, IN, USA) and MMLV reverse transcriptase (Epicentre Technologies, Madison, WI, USA). After a 1-h incubation at 37degreesC, the reaction mixtures were heat inactivated at 92degreesC for 10 min and then applied as templates to amplify cDNAs specific for SERPINI1 (amplified with the forward primer 5'-CTTGCAATGGGAATGATGGAACTTG-3' and the reverse primer 5'-CGAAATCATGTCCACTTGTGTTCAT-3' at 1 cycle of 94degreesC for 5 min; 35 cycles of 94degreesC for 30 sec, 55degreesC for 30 sec, and 72degreesC for 90 sec; and 1 cycle of 72degreesC for 10 min) and for PDCD10 (amplified with the forward primer 5'-TCCATGGTTTCTATGCCCCT-3' and the reverse primer 5'-TTTGGTGTTCAAGTGCCCTG-3' at 1 cycle of 94degreesC for 5 min; 35 cycles of 94degreesC for 30 sec, 55degreesC for 30 sec, and 72degreesC for 30 sec; and 1 cycle of 72degreesC for 10 min). GAPDH serving as internal control was amplified using the primer set 5'-CCTGCACCACCAACTGCTTA-3' and 5'-ACCCTGTTGCTGTAGCCAAA-3' to allow comparison of RNA levels among different samples. The PCR conditions for GAPDH were the same as those for PDCD10.
###end p 42
###begin title 43
5'-Rapid amplification of cDNA ends (RACE)
###end title 43
###begin p 44
###xml 255 264 255 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 419 426 419 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 898 907 868 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 911 918 881 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 57 62 <span type="species:ncbi:9606">human</span>
The 5'-RACE analysis was performed using the FirstChoice human brain RNA ligase-mediated (RLM)-RACE kit (Ambion). Two RNA adaptor primers were employed as forward primers according to the manufacturer's instruction. The reverse primers for the 5'-RACE of SERPINI1 were 5'-TAGGCTGTCATATCCCATTGAGTGG-3' for the outer primer and 5'-CAAGTTCCATCATTCCCATTGCAAG-3' for the inner primer. The reverse primers for the 5'-RACE of PDCD10 were 5'-CTCAGCTTCATTCTTCATCTCTTC-3' for the outer primer and 5'-CCTCATTCAAAAGCCAACTACAG-3' for the inner primer. Both the first and second rounds of PCR were performed with 1 cycle at 94degreesC for 3 min; 35 cycles at 94degreesC for 30 sec, 60degreesC for 30 sec, and 72degreesC for 30 sec; and 1 cycle at 72degreesC for 7 min. The PCR products were cloned into a T-tailed vector pGEM-T-Easy (Promega, Madison, WI, USA) followed by sequencing to determine the 5'-ends of SERPINI1 and PDCD10 transcripts.
###end p 44
###begin title 45
Construction of the reporter gene plasmids
###end title 45
###begin p 46
###xml 216 225 216 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 229 236 229 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 291 292 291 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 82 87 <span type="species:ncbi:9606">human</span>
###xml 619 623 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 653 656 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
All restriction enzymes were purchased from Takara. Genomic DNA was purified from human whole blood samples using the QIAamp Blood kit (Qiagen, Hilden, Germany). The various lengths of the intergenic segment between SERPINI1 and PDCD10 were obtained by PCR using the primers listed in Table 1 under the following condition: 1 cycle of 94degreesC for 5 min; 35 cycles of 94degreesC for 30 sec, 55degreesC for 30 sec, and 72degreesC for 30 sec; and 1 cycle of 72degreesC for 10 min. The amplified DNA fragments were then cloned into one of the three vectors: pGL3-Basic, pGL3-Promoter, or pGL3-Promoter with the original SV40 promoter being replaced by a CMV promoter.
###end p 46
###begin title 47
Transient transfection and promoter assays
###end title 47
###begin p 48
###xml 74 76 74 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 290 298 289 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
Cells were first seeded in 12-well culture plates at a density of 1.8 x 105 cells per well. Cells were then co-transfected with 3 mul of Lipofectamine 2000 (Gibco Invitrogen) and a mixture of 525 ng of DNA consisting of 500 ng of the tested pGL3 promoter constructs and 25 ng of the pRL-TK Renilla luciferase reporter plasmids (Promega) in a serum-free medium. After a 3-h incubation at 37degreesC, the transfection medium was replaced with fresh medium supplemented with 10% FBS and cells were incubated for another 24 h. After incubation, cells were washed twice with PBS and lysed by reporter lysis buffer (Promega). Cellular debris was removed after centrifugation at 10,000 x g for 5 min at 4degreesC. Cell extracts were then assayed for luciferase activity using a SIRIUS luminometer (Berthold, Bad Wildbad, Germany). In each experiment, cells were transfected with pGL3-Basic and pGL3-Promter plasmids that served as negative and positive control, respectively. To normalize transfection efficiency, the pRL-TK plasmids were co-transfected as an internal control.
###end p 48
###begin title 49
Abbreviations
###end title 49
###begin p 50
###xml 239 245 <span type="species:ncbi:9913">bovine</span>
The abbreviations used are: SERPINI1, serine protease inhibitor, clade I, member 1; PDCD10, programmed cell death 10; PARK2, parkin; PACRG, parkin co-regulated gene; CRYAB, alphaB-crystallin; HSPB2, heat shock 27 kDa protein 2; FBS, fetal bovine serum; GAPDH, glyseraldehyde-3-phosphate dehydrogenase; RACE, rapid amplification of cDNA ends; RT-PCR, reverse transcription-polymerase chain reaction.
###end p 50
###begin title 51
Authors' contributions
###end title 51
###begin p 52
PYC designed and performed the experiments, and analyzed the data. RHC helped conceive the project and participated in writing the manuscript. YKL assisted in drafting of the manuscript. CYC contributed in the early stages of the work and identification of the bidirectional promoter. SCL helped perform the Northern blot assays. CWW and WSWC supervised the project and oversaw the experiments. All authors read and approved the final manuscript.
###end p 52
###begin title 53
Acknowledgements
###end title 53
###begin p 54
We are grateful to Dr. Chiou-Hwa Yuh and Dr. Hwan-You Chang for helpful discussion. We also thank Ms. Celive Lim Yuan, Mr. Tz-Wei Lin and Mr. Yi-Chieh Perng for technical assistance. This work was supported mainly by the National Health Research Institutes (PA-092-PP-07, PA-094-PP-08 & CA-095-PP-36), and in part by the Department of Health (DOH94-TD-G-111-024) and National Science Council (NSC95-2752-B-007-004), Executive Yuan, Taiwan, R.O.C.
###end p 54
###begin article-title 55
MEROPS: the peptidase database
###end article-title 55
###begin article-title 56
The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature
###end article-title 56
###begin article-title 57
Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function
###end article-title 57
###begin article-title 58
Serpins in prokaryotes
###end article-title 58
###begin article-title 59
The serpin superfamily of proteinase inhibitors: structure, function, and regulation
###end article-title 59
###begin article-title 60
Cytoplasmic antiproteinase 2 (PI8) and bomapin (PI10) map to the serpin cluster at 18q21.3
###end article-title 60
###begin article-title 61
###xml 53 58 <span type="species:ncbi:9606">human</span>
A 370-kb cosmid contig of the serpin gene cluster on human chromosome 14q32.1: molecular linkage of the genes encoding alpha 1-antichymotrypsin, protein C inhibitor, kallistatin, alpha 1-antitrypsin, and corticosteroid-binding globulin
###end article-title 61
###begin article-title 62
SCCA1 and SCCA2 are proteinase inhibitors that map to the serpin cluster at 18q21.3
###end article-title 62
###begin article-title 63
###xml 25 30 <span type="species:ncbi:9606">human</span>
A serpin gene cluster on human chromosome 6p25 contains PI6, PI9 and ELANH2 which have a common structure almost identical to the 18q21 ovalbumin serpin genes
###end article-title 63
###begin article-title 64
Neuroserpin, an axonally secreted serine protease inhibitor
###end article-title 64
###begin article-title 65
###xml 42 47 <span type="species:ncbi:9606">human</span>
Isolation and characterization of a novel human pancreas-specific gene, pancpin, that is down-regulated in pancreatic cancer cells
###end article-title 65
###begin article-title 66
###xml 54 59 <span type="species:ncbi:9606">human</span>
Tissue-specific cancer-related serpin gene cluster at human chromosome band 3q26
###end article-title 66
###begin article-title 67
Tissue-type plasminogen activator and neuroserpin: a well-balanced act in the nervous system?
###end article-title 67
###begin article-title 68
Tissue plasminogen activator mRNA expression in granule neurons coincides with their migration in the developing cerebellum
###end article-title 68
###begin article-title 69
Neuroserpin regulates neurite outgrowth in nerve growth factor-treated PC12 cells
###end article-title 69
###begin article-title 70
###xml 123 128 <span type="species:ncbi:10090">mouse</span>
Expression of neuroserpin, an inhibitor of tissue plasminogen activator, in the developing and adult nervous system of the mouse
###end article-title 70
###begin article-title 71
Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers: implications for the epilepsy seen in the dementia FENIB
###end article-title 71
###begin article-title 72
Mutants of neuroserpin that cause dementia accumulate as polymers within the endoplasmic reticulum
###end article-title 72
###begin article-title 73
Conformational mutations in neuroserpin and familial dementias
###end article-title 73
###begin article-title 74
Latent S49P neuroserpin forms polymers in the dementia familial encephalopathy with neuroserpin inclusion bodies
###end article-title 74
###begin article-title 75
Familial dementia caused by polymerization of mutant neuroserpin
###end article-title 75
###begin article-title 76
Association between conformational mutations in neuroserpin and onset and severity of dementia
###end article-title 76
###begin article-title 77
###xml 58 63 <span type="species:ncbi:9606">human</span>
cDNA cloning and expression of an apoptosis-related gene, human TFAR15 gene
###end article-title 77
###begin article-title 78
###xml 38 60 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Systematic functional analysis of the Caenorhabditis elegans genome using RNAi
###end article-title 78
###begin article-title 79
Mutations within the Programmed Cell Death 10 Gene Cause Cerebral Cavernous Malformations
###end article-title 79
###begin article-title 80
###xml 47 52 <span type="species:ncbi:9606">human</span>
An abundance of bidirectional promoters in the human genome
###end article-title 80
###begin article-title 81
###xml 56 61 <span type="species:ncbi:9606">human</span>
The genes for the alpha 1(IV) and alpha 2(IV) chains of human basement membrane collagen type IV are arranged head-to-head and separated by a bidirectional promoter of unique structure
###end article-title 81
###begin article-title 82
Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively
###end article-title 82
###begin article-title 83
Comparative genome analysis of potential regulatory elements in the ABCG5-ABCG8 gene cluster
###end article-title 83
###begin article-title 84
Neuronal depolarization enhances the transcription of the neuronal serine protease inhibitor neuroserpin
###end article-title 84
###begin article-title 85
###xml 95 100 <span type="species:ncbi:9606">human</span>
Detecting correlation between sequence and expression divergences in a comparative analysis of human serpin genes
###end article-title 85
###begin article-title 86
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human ovalbumin serpin evolution: phylogenic analysis, gene organization, and identification of new PI8-related genes suggest that two interchromosomal and several intrachromosomal duplications generated the gene clusters at 18q21-q23 and 6p25
###end article-title 86
###begin article-title 87
###xml 84 89 <span type="species:ncbi:9606">human</span>
A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene
###end article-title 87
###begin article-title 88
###xml 66 71 <span type="species:ncbi:9606">human</span>
Characterization of the bidirectional promoter region between the human genes encoding VLCAD and PSD-95
###end article-title 88
###begin article-title 89
Identification of a novel gene linked to parkin via a bi-directional promoter
###end article-title 89
###begin article-title 90
###xml 43 48 <span type="species:ncbi:9606">human</span>
Identification and characterization of the human parkin gene promoter
###end article-title 90
###begin article-title 91
Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies
###end article-title 91
###begin article-title 92
Regulation of Dlx3 gene expression in visceral arches by evolutionarily conserved enhancer elements
###end article-title 92
###begin article-title 93
A HOX complex, a repressor element and a 50 bp sequence confer regional specificity to a DPP-responsive enhancer
###end article-title 93
###begin article-title 94
Identification of a novel repressive element that contributes to neuron-specific gene expression
###end article-title 94
###begin article-title 95
###xml 114 119 <span type="species:ncbi:10090">mouse</span>
Orientation-dependent influence of an intergenic enhancer on the promoter activity of the divergently transcribed mouse Shsp/alpha B-crystallin and Mkbp/HspB2 genes
###end article-title 95
###begin title 96
Figures and Tables
###end title 96
###begin p 97
###xml 26 35 26 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 39 46 39 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Northern blot analysis of <italic>SERPINI1 </italic>and <italic>PDCD10 </italic>in various tissues</bold>
###xml 146 148 146 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 175 183 175 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1</italic>
###xml 188 194 188 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 66 71 <span type="species:ncbi:9606">Human</span>
Northern blot analysis of SERPINI1 and PDCD10 in various tissues. Human MTE multiple tissue expression array II (BD Clontech) was hybridized with 32P-labeled probe against A) SERPINI1, B) PDCD10, and C) control ubiquitin, respectively. Panel D shows the individual designations of all tissues examined.
###end p 97
###begin p 98
###xml 30 39 30 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 0 85 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Relative expression levels of <italic>SERPINI1 </italic>and <italic>PDCD10 </italic>between normal and tumorous tissues</bold>
###xml 127 136 127 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 140 147 140 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 507 510 507 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDC</italic>
###xml 214 219 <span type="species:ncbi:9606">human</span>
###xml 245 250 <span type="species:ncbi:9606">human</span>
###xml 294 299 <span type="species:ncbi:9606">human</span>
Relative expression levels of SERPINI1 and PDCD10 between normal and tumorous tissues. A) Semi-quantitative RT-PCR analysis of SERPINI1 and PDCD10 transcripts. RNAs used in this study were obtained from the normal human brain (Lanes 2, 6 & 10), human neuroglioma H4 cells (Lanes 3, 7 & 11) and human glioblastoma U-87 MG cells (Lanes 4, 8 & 12). M indicates the DNA size markers; and Lanes 1, 5 & 9 are the negative controls without templates in the PCR reactions. B & C) Northern hybridization analysis of PDCD10 (B) and ubiquitin (C) in paired normal/tumor tissue samples (BD Clontech). The array order of all tissues examined is shown in panel D.
###end p 98
###begin p 99
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 55 64 55 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 0 111 0 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Analysis of the intergenic distance between <italic>PDCD10 </italic>and <italic>SERPINI1 </italic>and its promoter activity in various cell lines</bold>
###xml 148 155 148 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 159 168 159 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 294 301 294 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 305 314 305 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 473 480 473 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 483 491 483 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1</italic>
###xml 576 581 <span type="species:ncbi:9606">human</span>
###xml 598 603 <span type="species:ncbi:9606">human</span>
###xml 632 637 <span type="species:ncbi:9606">human</span>
###xml 672 677 <span type="species:ncbi:9606">human</span>
###xml 705 710 <span type="species:ncbi:9606">human</span>
###xml 745 748 <span type="species:ncbi:10116">rat</span>
Analysis of the intergenic distance between PDCD10 and SERPINI1 and its promoter activity in various cell lines. A) The intergenic distance between PDCD10 and SERPINI1 was 851 bp, as determined from the results of 5'-RACE. The nucleotides between the two closest transcriptional start sites of PDCD10 and SERPINI1 are numbered from the centromeric (cen) end to the telomeric (tel) end. B) The promoter activity of the intergenic 851-bp fragment in either direction (toward PDCD10 or SERPINI1) was determined by the firefly luciferase assay in 6 different cell lines including human neuroglioma H4, human brain glioblastoma U-87 MG, human ovarian adenocarcinoma OVTW-59-4, human lung adenocarcinoma CL1-5, human cervical adenocarcinoma HeLa, and rat adrenal gland pheochromocytoma PC-12 cells.
###end p 99
###begin p 100
###xml 60 66 60 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 67 76 67 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 0 85 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sequence analysis of the intergenic region of the divergent <italic>PDCD10</italic>-<italic>SERPINI1 </italic>gene pair</bold>
###xml 148 154 148 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 155 164 155 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 418 425 418 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 429 437 429 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1</italic>
###xml 142 147 <span type="species:ncbi:9606">human</span>
###xml 183 188 <span type="species:ncbi:10090">mouse</span>
###xml 197 200 <span type="species:ncbi:10116">rat</span>
###xml 412 417 <span type="species:ncbi:9606">human</span>
Sequence analysis of the intergenic region of the divergent PDCD10-SERPINI1 gene pair. Dot matrix alignment of the intergenic sequence of the human PDCD10-SERPINI1 pair with those of mouse (A) and rat (B). The units in both vertical and horizontal axis are the position numbers of the nucleotides in the intergenic region as shown in Fig. 3A. C) The complete nucleotide sequence of the intergenic spacer between human PDCD10 and SERPINI1. The putative transcription factor binding sites are underlined. The transcriptional start sites confirmed by 5'-RACE are indicated by bended arrows. The shaded nucleotides indicate the transcriptional start sites of the reference sequence reported by the NCBI database. The arrowheads indicate the cutting sites for the deletion assays described in Fig. 5.
###end p 100
###begin p 101
###xml 67 73 67 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 74 83 74 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 0 92 0 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Identification of the minimal bidirectional promoter region of the <italic>PDCD10</italic>-<italic>SERPINI1 </italic>gene pair</bold>
###xml 346 354 346 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
###xml 480 488 480 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
###xml 764 770 764 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 856 864 856 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1</italic>
###xml 290 295 <span type="species:ncbi:9606">human</span>
###xml 954 958 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Identification of the minimal bidirectional promoter region of the PDCD10-SERPINI1 gene pair. The 5'- and 3'-deleted putative promoter fragments were individually cloned into the upstream of the firefly luciferase gene (LUC) in the pGL3-Basic vector followed by transient transfection into human neuroglioma H4 cells. The pRL-TK plasmid carrying Renilla luciferase gene was co-transfected as the internal control. The relative firefly luciferase activities were normalized to the Renilla luciferase activities to correct the transfection efficiency. The length and the position of each promoter insert are shown in scale. The numbers denote the positions of nucleotides with respect to +1, the first intergenic nucleotide next to the transcriptional start site of PDCD10, and +851, the intergenic nucleotide right next to the transcriptional start site of SERPINI1. The empty boxes represent inserted intergenic sequences. The shaded boxes represent the SV40 promoter.
###end p 101
###begin p 102
###xml 94 100 94 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10</italic>
###xml 101 110 101 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 0 119 0 119 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Identification of the enhancer and the repressive element within the intergenic region of the <italic>PDCD10</italic>-<italic>SERPINI1 </italic>gene pair</bold>
###xml 784 791 784 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDCD10 </italic>
###xml 1005 1014 1005 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SERPINI1 </italic>
###xml 185 189 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 193 196 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 309 314 <span type="species:ncbi:9606">human</span>
###xml 449 453 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 457 460 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 623 627 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 678 682 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 842 846 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 903 907 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1065 1068 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1151 1154 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1389 1393 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1421 1424 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Identification of the enhancer and the repressive element within the intergenic region of the PDCD10-SERPINI1 gene pair. Various intergenic fragments were cloned upstream of either the SV40 or CMV promoter and of a luciferase reporter gene in the pGL3 vector. All constructs were transiently transfected into human neuroglioma H4 cells and the luciferase activity was measured. The resulting promoter activity was calculated relative to the control SV40 or CMV promoter activity which is artificially set at 100. A) The potential regulatory sequences from nt 176 to 851 of the intergenic region were cloned upstream of the SV40 promoter and their effects on the activity of the SV40 promoter were examined. B) Three intergenic fragments (nt 851-711, nt 710-474 and nt 473-176) in the PDCD10 direction were individually cloned upstream of the SV40 promoter to assess their effects on the activity of the SV40 promoter. C) Three different intergenic fragments (nt 711-851, nt 474-710 and nt 176-473) in the SERPINI1 direction were individually cloned upstream of the CMV promoter in a modified pGL3-Promoter vector. Their effects on the activity of the CMV promoter were then investigated. The numbering system for nucleotide position is the same as those described in Fig. 5. The length and the position of each promoter insert are shown in scale. In the names of constructs, S denotes the SV40 promoter and C denotes the CMV promoter.
###end p 102
###begin p 103
Primer sequences used to amplify intergenic fragments for subsequent cloning
###end p 103
###begin p 104
###xml 134 138 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 272 275 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
*Construct names with an "S" character at the end indicates that the PCR-amplified intergenic product was cloned into the upstream of SV40 minimal promoter. Construct names with a "C" character denotes that the amplified intergenic segment was cloned into the upstream of CMV promoter.
###end p 104

